Dabigatran vs Tofacitinib

Dabigatran vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Dabigatran and Tofacitinib.

Mechanism of Action

Dabigatran: Direct thrombin (Factor IIa) inhibitor.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Dabigatran — 12-17 hours; Tofacitinib — 3.2 hours.

Chemical Properties

Molecular Formula: Dabigatran — C25H25N7O3; Tofacitinib — C16H20N6O.

Molecular Weight: Dabigatran — 471.5100 g/mol; Tofacitinib — 312.3700 g/mol.

Type: Dabigatran — Small molecule; Tofacitinib — Small molecule.